Back
Pernod Ricard SA Vs. Denali Therapeutics Industry Stock Comparison
Sell
12
PRNDY
Pernod Ricard SA
Last Price:
28.71
Seasonality Move:
4.31%
Buy
56
DNLI
Denali Therapeutics
Last Price:
31.75
Seasonality Move:
17.79%
Sell
12
Pernod Ricard SA (PRNDY)
is a Sell
Is Pernod Ricard SA a Buy, Sell or Hold?
- The current Pernod Ricard SA [PRNDY] share price is $27.73. The Score for PRNDY is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- PRNDY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.76. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PRNDY Stock Price Chart
What is Pernod Ricard SA's stock price today?
-
The Pernod Ricard SA share price today is $27.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRNDY is experiencing selling pressure, which indicates risk of future bearish movement.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
PRNDY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 48.64 | Sell |
| Chaikin Money Flow: | -38779 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.34 - 28.48) | Sell |
| Bollinger Bands (100): | (27.01 - 30.37) | Sell |
DNLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.79 | Buy |
| Relative Strength Index (14 RSI): | 78.12 | Buy |
| Chaikin Money Flow: | -939708 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.39 - 28.19) | Buy |
| Bollinger Bands (100): | (19.07 - 25.27) | Buy |
PRNDY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.97 | Sell |
| 20-day SMA: | 28.1 | Sell |
| 50-day SMA: | 27.56 | Buy |
| 200-day SMA: | 30.82 | Sell |
| 8-day EMA: | 27.98 | Sell |
| 20-day EMA: | 27.9 | Sell |
| 50-day EMA: | 27.95 | Sell |
| 200-day EMA: | 30.84 | Sell |
DNLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.69 | Buy |
| 20-day SMA: | 26.4 | Buy |
| 50-day SMA: | 24.37 | Buy |
| 200-day SMA: | 20.59 | Buy |
| 8-day EMA: | 29.03 | Buy |
| 20-day EMA: | 26.97 | Buy |
| 50-day EMA: | 24.8 | Buy |
| 200-day EMA: | 22.21 | Buy |
Pernod Ricard SA Earnings Growth & PRNDY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Pernod Ricard SA Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Denali Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||